Design and Rationale of the EMPA‐VISION Trial: Investigating the Metabolic Effects of Empagliflozin in Patients with Heart Failure
ESC heart failure(2021)
Key words
Heart failure,Diabetes,SGLT2 inhibitors,P-31-MRS,Trial design,Empagliflozin
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined